WhitTier Trust Company’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-33,550
| Closed | -$3.33M | – | 1037 |
|
|
2019
Q3 | $3.33M | Buy |
33,550
+150
| +0.4% | +$14.3K | 0.23% | 101 |
|
|
2019
Q2 | $3.09M | Buy |
33,400
+196
| +0.6% | +$18.6K | 0.22% | 106 |
|
|
2019
Q1 | $3.13M | Buy |
33,204
+356
| +1% | +$31.1K | 0.23% | 106 |
|
|
2018
Q4 | $2.11M | Sell |
32,848
-1,434
| -4% | -$106K | 0.17% | 122 |
|
|
2018
Q3 | $3.07M | Sell |
34,282
-54
| -0.2% | -$4.77K | 0.22% | 109 |
|
|
2018
Q2 | $2.73M | Buy |
34,336
+123
| +0.4% | +$10.2K | 0.21% | 114 |
|
|
2018
Q1 | $3.05M | Buy |
34,213
+510
| +2% | +$49K | 0.25% | 101 |
|
|
2017
Q4 | $3.52M | Sell |
33,703
-9,461
| -22% | -$1.07M | 0.3% | 92 |
|
|
2017
Q3 | $6.29M | Buy |
43,164
+538
| +1% | +$73.3K | 0.59% | 51 |
|
|
2017
Q2 | $5.54M | Buy |
42,626
+714
| +2% | +$87.5K | 0.54% | 57 |
|
|
2017
Q1 | $5.21M | Sell |
41,912
-3,257
| -7% | -$390K | 0.52% | 58 |
|
|
2016
Q4 | $5.23M | Buy |
45,169
+171
| +0.4% | +$19K | 0.56% | 52 |
|
|
2016
Q3 | $4.7M | Sell |
44,998
-1,935
| -4% | -$209K | 0.53% | 57 |
|
|
2016
Q2 | $4.63M | Buy |
46,933
+1,055
| +2% | +$109K | 0.53% | 59 |
|
|
2016
Q1 | $4.59M | Sell |
45,878
-59
| -0.1% | -$6.08K | 0.54% | 57 |
|
|
2015
Q4 | $5.5M | Buy |
45,937
+4,260
| +10% | +$493K | 0.64% | 49 |
|
|
2015
Q3 | $4.51M | Buy |
41,677
+2,263
| +6% | +$281K | 0.55% | 56 |
|
|
2015
Q2 | $4.56M | Buy |
39,414
+2,953
| +8% | +$338K | 0.51% | 63 |
|
|
2015
Q1 | $4.2M | Sell |
36,461
-200
| -0.5% | -$23.9K | 0.47% | 69 |
|
|
2014
Q4 | $4.1M | Sell |
36,661
-191
| -0.5% | -$20.1K | 0.46% | 68 |
|
|
2014
Q3 | $3.49M | Buy |
36,852
+312
| +0.9% | +$28.2K | 0.4% | 73 |
|
|
2014
Q2 | $3.14M | Sell |
36,540
-2,316
| -6% | -$176K | 0.35% | 76 |
|
|
2014
Q1 | $2.71M | Buy |
38,856
+2,556
| +7% | +$202K | 0.32% | 81 |
|
|
2013
Q4 | $3.07M | Sell |
36,300
-2,234
| -6% | -$177K | 0.37% | 76 |
|
|
2013
Q3 | $2.97M | Buy |
38,534
+3,398
| +10% | +$238K | 0.4% | 75 |
|
|
2013
Q2 | $2.06M | Buy |
+35,136
| New | +$2.11M | 0.3% | 82 |
|
Other funds holding CELG
FP
HCM
PCMC
WCG
WhitTier Trust Company's CELG Position: Q4 2019 in Review
WhitTier Trust Company sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 33,550 shares — an estimated $3.33M sold.
WhitTier Trust Company first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $6.29M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- WhitTier Trust Company reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- WhitTier Trust Company sold 33,550 Celgene Corp shares in Q4 2019, an estimated $3.33M.
- WhitTier Trust Company first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
- WhitTier Trust Company's Celgene Corp position peaked at $6.29M in Q3 2017.
- 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on WhitTier Trust Company's 13F filing for Q4 2019, filed 31 Jan 2020.